For instance, in the context of cardiovascular diseases, GM-CSF is pro-atherogenic: it exacerbates atherosclerosis by promoting infiltration and activation of immune cells, facilitating plaque progression, and possibly increasing vascularization within plaques, thus reducing their stability and increasing the risk of plaque rupture (9, 11, 59). Here, CSF2 is linked to atherosclerosis.